Hybrid artificial intelligence approaches and bioimpedance spectroscopy for classifying pancreatic disease.

This research develops bioimpedance spectroscopy methods aimed at improving the differential diagnosis of pancreatic diseases. A novel approach for forming descriptors from bioimpedance data is introduced, which involves analyzing four amplitude-phase-frequency characteristics obtained from quasi-orthogonal leads. This method establishes informative feature spaces utilized by a hybrid classifier specifically designed to differentiate between pancreatitis and pancreatic cancer. The hybrid classifier comprises five macro layers, integrating probabilistic neural networks and fuzzy logical inference. Comprehensive experimental software studies and clinical tests validate the system's performance, demonstrating diagnostic sensitivity and specificity levels comparable to established techniques. The findings suggest that utilizing multifrequency bioimpedance measurements in neural network classifiers enhances the accuracy of clinical decision-making, potentially leading to better diagnostic outcomes for pancreatic diseases.